116 related articles for article (PubMed ID: 8250542)
1. Modulatory effect of N-acetyl-L-cysteine on the HIV-1 multiplication in chronically and acutely infected cell lines.
Pani A; Marongiu ME; La Colla P
Antiviral Res; 1993 Sep; 22(1):31-43. PubMed ID: 8250542
[TBL] [Abstract][Full Text] [Related]
2. N-acetyl-cysteine and L-2-oxothiazolidine-4-carboxylic acid enhance contact-dependent growth of HIV in resting peripheral blood mononuclear cells (PBMC) in vitro and increase recovery of HIV from human-PBMC SCID mice.
Chen P; Bauer G; Mitchell J; Factor R; Markham R; Schwartz DH
AIDS; 1997 Jan; 11(1):33-41. PubMed ID: 9110073
[TBL] [Abstract][Full Text] [Related]
3. Synergistic drug interactions of an HIV-1 protease inhibitor with AZT in different in vitro models of HIV-1 infection.
Lambert DM; Bartus H; Fernandez AV; Bratby-Anders C; Leary JJ; Dreyer GB; Metcalf BW; Petteway SR
Antiviral Res; 1993 Aug; 21(4):327-42. PubMed ID: 7692816
[TBL] [Abstract][Full Text] [Related]
4. Selective antiviral activity of synthetic soluble L-tyrosine and L-dopa melanins against human immunodeficiency virus in vitro.
Montefiori DC; Zhou JY
Antiviral Res; 1991 Jan; 15(1):11-25. PubMed ID: 1709802
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin antagonists inhibit human immunodeficiency virus-induced cell fusion but not virus replication.
Srinivas RV; Bernstein H; Oliver C; Compans RW
AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1489-96. PubMed ID: 7888203
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of 12-methoxydodecanoate into the human immunodeficiency virus 1 gag polyprotein precursor inhibits its proteolytic processing and virus production in a chronically infected human lymphoid cell line.
Bryant ML; Ratner L; Duronio RJ; Kishore NS; Devadas B; Adams SP; Gordon JI
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2055-9. PubMed ID: 2006142
[TBL] [Abstract][Full Text] [Related]
7. Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitro.
Witvrouw M; Schmit JC; Van Remoortel B; Daelemans D; Esté JA; Vandamme AM; Desmyter J; De Clercq E
AIDS Res Hum Retroviruses; 1997 Jan; 13(2):187-92. PubMed ID: 9007204
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-stimulated human immunodeficiency virus replication is inhibited by N-acetyl-L-cysteine.
Roederer M; Staal FJ; Raju PA; Ela SW; Herzenberg LA; Herzenberg LA
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4884-8. PubMed ID: 2112750
[TBL] [Abstract][Full Text] [Related]
9. Oxophenarsine, an antisyphilis drug inhibits HIV-1-specific protein synthesis in acutely and persistently infected lymphocytes.
Gupta P; Balachandran R; Thampatty P; Rinaldo C; Ho M
AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1417-23. PubMed ID: 2078419
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of HIV-1 replication by hydroxychloroquine: mechanism of action and comparison with zidovudine.
Chiang G; Sassaroli M; Louie M; Chen H; Stecher VJ; Sperber K
Clin Ther; 1996; 18(6):1080-92. PubMed ID: 9001825
[TBL] [Abstract][Full Text] [Related]
11. Papaverine hydrochloride: effects on HIV replication and T-lymphocyte cell function.
Nokta M; Albrecht T; Pollard R
Immunopharmacology; 1993; 26(2):181-5. PubMed ID: 7506701
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of human immunodeficiency virus type 1 multiplication by transforming growth factor beta 1 and AZT in HIV-1-infected myeloid cells.
McKiel V; Gu Z; Wainberg MA; Hiscott J
J Interferon Cytokine Res; 1995 Oct; 15(10):849-55. PubMed ID: 8564706
[TBL] [Abstract][Full Text] [Related]
13. Effects of serotonin and melanin on in vitro HIV-1 infection.
Sidibe S; Saal F; Rhodes-Feuillette A; Lagaye S; Pelicano L; Canivet M; Peries J; Dianoux L
J Biol Regul Homeost Agents; 1996; 10(1):19-24. PubMed ID: 9049777
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine inhibits latent HIV expression in chronically infected cells.
Roederer M; Raju PA; Staal FJ; Herzenberg LA; Herzenberg LA
AIDS Res Hum Retroviruses; 1991 Jun; 7(6):563-7. PubMed ID: 1931232
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of human immunodeficiency virus type 1 replication by novel fluoroalkylated oligomers in vitro.
Baba M; Kira T; Shigeta S; Matsumoto T; Sawada H
J Acquir Immune Defic Syndr (1988); 1994 Jan; 7(1):24-30. PubMed ID: 8263750
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivatives.
Mihm S; Ennen J; Pessara U; Kurth R; Dröge W
AIDS; 1991 May; 5(5):497-503. PubMed ID: 1907460
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha but not AZT suppresses HIV expression in chronically infected cell lines.
Poli G; Orenstein JM; Kinter A; Folks TM; Fauci AS
Science; 1989 May; 244(4904):575-7. PubMed ID: 2470148
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human immunodeficiency virus (HIV-1) infection by diphenylhydantoin (dilantin) implicates role of cellular calcium in virus life cycle.
Cloyd MW; Lynn WS; Ramsey K; Baron S
Virology; 1989 Dec; 173(2):581-90. PubMed ID: 2574518
[TBL] [Abstract][Full Text] [Related]
19. Pentoxifylline inhibits acute HIV-1 replication in human T cells by a mechanism not involving inhibition of tumour necrosis factor synthesis or nuclear factor-kappa B activation.
Navarro J; Punzón MC; Pizarro A; Fernández-Cruz E; Fresno M; Muñoz-Fernández MA
AIDS; 1996 May; 10(5):469-75. PubMed ID: 8724037
[TBL] [Abstract][Full Text] [Related]
20. Appraisal of potential therapeutic index of antioxidants on the basis of their in vitro effects on HIV replication in monocytes and interleukin 2-induced lymphocyte proliferation.
Aillet F; Gougerot-Pocidalo MA; Virelizier JL; Israël N
AIDS Res Hum Retroviruses; 1994 Apr; 10(4):405-11. PubMed ID: 7915123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
